Novo Nordisk invests $2.3 bln to new production facility for producing chronic diseases curing products

The Danish drugmaker, Novo Nordisk, announced that it will invest 15.9 billion Danish crowns ($2.29 billion) to expand a new production facility in Denmark for producing chronic diseases curing products …

Novo Nordisk invests $2.3 bln to new production facility for producing chronic diseases curing products Read More